An internal conflict among GOP members regarding intoxicating hemp products is hindering the progress of a government funding bill. The Senate’s funding bill, expected to be reviewed this week, proposes to postpone the upcoming ban on most hemp-derived THC products by a month, moving it to December 11. This decision was made following pressure from the White House, catching some senators off guard.
Senator Ted Budd (R-N.C.) and several other Republicans have voiced their objections to this delay. They are pressing for a vote on an amendment to remove this provision, primarily due to concerns about easy accessibility of hemp-derived THC products to children. On the other hand, the administration has been clear about their stance, advocating for the delay. President Trump, in April, expressed on Truth Social his desire for Congress to update laws to ensure Americans can continue to access full-spectrum CBD products while maintaining restrictions on products posing health risks.
During discussions in June involving the House’s Agriculture, Rural Development, and FDA package, the Office of Management and Budget expressed readiness to work with Congress. They aim to update definitions of hemp-derived cannabinoid products, allowing access to beneficial CBD products while restricting harmful ones. At that time, various hemp-related amendments were dismissed by lawmakers. These amendments aimed to either extend the ban by two years, eliminate it entirely, or replace it with a regulated and taxed system.
The current debate focuses on a law passed late last year which sought to refine the definition of hemp. Critics had pointed out a ‘hemp loophole’ following the 2018 Farm Bill, which had removed hemp from the controlled substances list. The loophole allowed companies to extract and synthesize high THC levels, the psychoactive component in marijuana. Products like gummies and beverages gained popularity, sold outside dispensaries, and extended to places like gas stations and major retailers. These items often resemble candy and lack consistent age restrictions or labeling.
The new legal definition restricts hemp products to 0.4 milligrams of total THC per container or any other cannabinoid with similar effects. Initially set to be effective November 12, this change might now be delayed. Products synthesized and incapable of being naturally produced by Cannabis sativa L. plants will still be banned on the original date. This likely includes illicit products originating from China.
Essential Healthcare Updates
The Senate Homeland Security and Governmental Affairs Committee plans to vote on a resolution to hold Dr. Anthony Fauci in contempt of Congress after he invoked the Fifth Amendment in a recent committee hearing. CDC will welcome a new official director, Dr. Erica Schwartz, following a Senate vote confirming her on a 51-44 majority.
Other Healthcare News
Nationwide, additional states have been linked to an outbreak of cyclosporiasis, with Missouri also confirming its involvement. A new Medical Aid in Dying Act is now in effect in New York, while California faces setbacks as millions lose healthcare coverage despite nearing universal healthcare.
North Carolina Congressman Withdraws Amid Ethics Committee’s Censure Recommendation 
Progressive Candidates Face Crucial November Tests 
Nominee Todd Blanche Under Scrutiny Amid Epstein-Related Lawsuit 
Democrats Accuse Energy Secretary of Misleading Congress 
Trump Secures Major Immigration Win With Supreme Court Decision 
Trump Shares Melania’s Criticisms of His Rally Performances